Novartis has claimed accelerated approval from the FDA for a second indication for Fabhalta – IgA nephropathy (IgAN) – as it charts a course to blockbuster sales for the drug. The US regulator has ...
Abstract: Sixth-generation (6G) mobile communication networks are expected to have dense infrastructures, large antenna size, wide bandwidth, cost-effective hardware, diversified positioning methods, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback